Effectiveness of Virtual Care Team Guided Management of Hospitalized Patients with HFrEF by Ethnicity.
Dec 17, 2024DOI: 10.1016/j.cardfail.2024.11.018Journal ArticleJCF
Written by: John H BertotAnubodh S VarshneyAlea MosconeBrian L ClaggettZi Michael MiaoMuhammad AkashMaria PabonJonathan W CunninghamTracy MakuvireScott D SolomonDale S AdlerMuthiah VaduganathanAnkeet S Bhatt
Find these authors on Roon
SV
Dr. Sunny Varshney
Advanced Heart Failure · Stanford
DA
Dr. Dale Adler
General Cardiology · BWH
AB
Dr. Ankeet Bhatt
General Cardiology · Kaiser Permanente
Summary
BACKGROUND: The Implementation of Medical Therapy in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction (IMPLEMENT-HF) study demonstrated that a virtual team-based care strategy was safe and improved prescription of guideline-directed medical therapy (GDMT) in hospitalized patients with heart failure and reduced ejection fraction (HFrEF). We evaluated differences in efficacy and safety outcomes by ethnicity in IMPLEMENT-HF.METHODS: IMPLEMENT-HF evaluated a provider-facing virtual team-based care strategy versus usual care in hospitalized patients with HFrEF from October 2021 to June 2022. The primary outcome was change in a GDMT optimization score from hospital admission to discharge, with positive changes reflecting net optimization. In this post-hoc analysis, we assessed heterogeneity in treatment effects by ethnicity (Hispanic vs. non-Hispanic). Outcomes included prespecified primary and secondary effectiveness outcomes and adjudicated safety events.RESULTS: Of 808 screened patient admissions, 252 (31%) from 198 unique patients met inclusion criteria. Hispanic patients (n = 43) were more likely to have diabetes and end-stage kidney disease than non-Hispanics; 70% spoke Spanish as a primary language. GDMT optimization score was lower among Hispanic versus non-Hispanic patients (-0.44; 95% CI -1.88 to 0.99 vs. +1.62, 95% CI +1.02 to +2.21; P value of interaction by ethnicity = .002). Allocation to the virtual care team intervention versus usual care increased the proportion of patients experiencing >1 new initiation or dose up-titration among non-Hispanic patients but did not among Hispanic patients (absolute difference non-Hispanic vs. Hispanic: +31% vs. -19%; P value of interaction = .003). Similar trends were seen among individual HF therapy and for the proportion of patients with optimization score >0 (absolute difference non-Hispanic vs. Hispanic: +29% vs. -20%; P value of interaction = .005). Safety outcomes were similar among Hispanic and non-Hispanic patients.CONCLUSION: A provider-facing, virtual care team-guided strategy for HFrEF GDMT optimization was less effective in Hispanic patients. Efforts to identify and reduce bias and equity assessments in implementation studies are needed.
DA
Dr. Dale Adler
Cardiology · General Non-Invasive CardiologyBrigham and Women's Hospitaldale